Seizure activity and unresponsiveness after hydroxycut ingestion

A 22-year-old man was hospitalized after unexplained seizure-like activity and unresponsiveness. A urine toxicology screen was negative for salicylates, acetaminophen, alcohol, and drugs of abuse. Medical history was insignificant with the exception of recent (within 2 wks) ingestion of Hydroxycut i...

Full description

Saved in:
Bibliographic Details
Published inPharmacotherapy Vol. 21; no. 5; p. 647
Main Authors Kockler, D R, McCarthy, M W, Lawson, C L
Format Journal Article
LanguageEnglish
Published United States 01.05.2001
Subjects
Online AccessGet more information

Cover

Loading…
Abstract A 22-year-old man was hospitalized after unexplained seizure-like activity and unresponsiveness. A urine toxicology screen was negative for salicylates, acetaminophen, alcohol, and drugs of abuse. Medical history was insignificant with the exception of recent (within 2 wks) ingestion of Hydroxycut is a dietary supplement purported to be energy enhancing, muscle building, and fat burning. The agent contains ephedra alkaloids and caffeine, which are both central nervous system stimulants; the etiology of seizure was attributed to their consumption. Due to a significant number of reported adverse events, the United States Food and Drug Administration (FDA) proposed regulations for dietary supplements containing ephedra alkaloids and requested an independent review of case reports linked to these products. Because herbal products are not subject to the same rigorous FDA regulations required for prescription and over-the-counter products, consumers unknowingly risk adverse effects when taking these products. Questioning patients about consumption of herbal products should be part of routine medical visits.
AbstractList A 22-year-old man was hospitalized after unexplained seizure-like activity and unresponsiveness. A urine toxicology screen was negative for salicylates, acetaminophen, alcohol, and drugs of abuse. Medical history was insignificant with the exception of recent (within 2 wks) ingestion of Hydroxycut is a dietary supplement purported to be energy enhancing, muscle building, and fat burning. The agent contains ephedra alkaloids and caffeine, which are both central nervous system stimulants; the etiology of seizure was attributed to their consumption. Due to a significant number of reported adverse events, the United States Food and Drug Administration (FDA) proposed regulations for dietary supplements containing ephedra alkaloids and requested an independent review of case reports linked to these products. Because herbal products are not subject to the same rigorous FDA regulations required for prescription and over-the-counter products, consumers unknowingly risk adverse effects when taking these products. Questioning patients about consumption of herbal products should be part of routine medical visits.
Author McCarthy, M W
Kockler, D R
Lawson, C L
Author_xml – sequence: 1
  givenname: D R
  surname: Kockler
  fullname: Kockler, D R
  organization: Department of Pharmacy Services, Drug Information Center, University of Virginia Health System, Charlottesville 22908-0674, USA
– sequence: 2
  givenname: M W
  surname: McCarthy
  fullname: McCarthy, M W
– sequence: 3
  givenname: C L
  surname: Lawson
  fullname: Lawson, C L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11349754$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tKAzEUQLOo2Id-gSD5gRnzzmSnFF9QcNG6LpnkxkZsZkhmiuPXK6icxdkdOEs0S10ChK4oqak07KY_uK5mtFa1ErrmQgo2QwvCtK4IIc0cLUt5J4RRJdg5mlPKhdFSLNDtFuLXmAFbN8RTHCZsk8djylD6LpV4ggSlYBsGyPgw-dx9Tm4ccExvUIbYpQt0FuxHgcs_r9Drw_1u_VRtXh6f13ebynHd6Mow7k1jXAhO2tYq4IoLp6TjtqFMt1wCdZ6BheDED84r1dJWKSOUBR7YCl3_dvuxPYLf9zkebZ72_yvsG4-XTno
CitedBy_id crossref_primary_10_1081_CLT_58946
crossref_primary_10_1007_s00210_019_01786_0
crossref_primary_10_1089_jcr_2012_0021
crossref_primary_10_1081_CLT_44771
crossref_primary_10_2165_00128415_200108600_00019
crossref_primary_10_1211_fact_2001_00309
crossref_primary_10_1016_j_jand_2016_02_015
crossref_primary_10_1176_appi_psy_44_6_508
crossref_primary_10_1213_01_ane_0000246444_65298_54
crossref_primary_10_2146_ajhp050270
crossref_primary_10_1136_bcr_2012_007509
crossref_primary_10_2146_ajhp070640
crossref_primary_10_4253_wjge_v5_i4_180
crossref_primary_10_1007_s12245_009_0105_z
crossref_primary_10_1093_jn_131_12_3319
crossref_primary_10_3810_psm_2003_12_592
crossref_primary_10_1097_00042752_200207000_00003
crossref_primary_10_1016_j_emc_2005_03_011
crossref_primary_10_1016_j_toxlet_2003_07_006
crossref_primary_10_1016_j_fct_2016_07_001
crossref_primary_10_1016_j_clinthera_2014_08_012
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1592/phco.21.6.647.34542
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
ExternalDocumentID 11349754
Genre Journal Article
Case Reports
GroupedDBID ---
.GJ
.Y3
05W
0R~
0VX
123
1CY
1OB
1OC
31~
33P
34G
39C
3SF
4.4
50Z
52U
52V
53G
5RE
8-0
8-1
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AAQQT
AASGY
AAXRX
AAYCA
AAYOK
AAZKR
ABCUV
ABJNI
ABLJU
ABOCM
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BRXPI
CGR
CS3
CUY
CVF
DCZOG
DPXWK
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
ECM
EIF
EJD
EMOBN
F5P
FEDTE
FUBAC
G-S
GODZA
GWYGA
H.X
HGLYW
HVGLF
HZ~
J5H
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LSO
LUTES
LW6
LYRES
MEWTI
MJL
MK0
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N04
N05
NF~
NPM
O66
O9-
P2P
P2W
PALCI
PQQKQ
Q.N
QB0
R.K
RIWAO
RJQFR
ROL
SAMSI
SJN
SUPJJ
SV3
TUS
TWZ
UDS
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WVDHM
WXSBR
YCJ
ZGI
ZXP
ZZTAW
~WT
ID FETCH-LOGICAL-c3787-923d989cffc5aba6e3634c65c3a8127b35e1cd2eaefc4c4ccd66b1b66946ae3f2
ISSN 0277-0008
IngestDate Wed Feb 19 01:26:33 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3787-923d989cffc5aba6e3634c65c3a8127b35e1cd2eaefc4c4ccd66b1b66946ae3f2
PMID 11349754
ParticipantIDs pubmed_primary_11349754
PublicationCentury 2000
PublicationDate May 2001
PublicationDateYYYYMMDD 2001-05-01
PublicationDate_xml – month: 05
  year: 2001
  text: May 2001
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Pharmacotherapy
PublicationTitleAlternate Pharmacotherapy
PublicationYear 2001
SSID ssj0021642
Score 1.7446661
Snippet A 22-year-old man was hospitalized after unexplained seizure-like activity and unresponsiveness. A urine toxicology screen was negative for salicylates,...
SourceID pubmed
SourceType Index Database
StartPage 647
SubjectTerms Adult
Caffeine - adverse effects
Central Nervous System Stimulants - adverse effects
Citrates - adverse effects
Drug Combinations
Drugs, Chinese Herbal - adverse effects
Ephedra sinica
Ephedrine - adverse effects
Humans
Male
Phytotherapy
Picolinic Acids - adverse effects
Plant Preparations
Polysaccharides - adverse effects
Seizures - chemically induced
Seizures - psychology
Theobromine - adverse effects
Theophylline - adverse effects
Title Seizure activity and unresponsiveness after hydroxycut ingestion
URI https://www.ncbi.nlm.nih.gov/pubmed/11349754
Volume 21
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELYKXPaCeC1v5APiAsk2cew2NxAPIaAIiSJxQ_bEUTnQVqIcyq9nxnGaUGAFKFIU2VHk5JuM5uH5hrHdphYQi6QVNNuQBkmmTaBt2wRoHcSG-NfbTaod7lyr87vk4l7eNxqH9eqSkQnh9dO6kt-gimOIK1XJ_gDZyUNxAK8RXzwjwnj-Fsa39vHVJQDA94CgKPgLEfi4fa9ejxVtwHvjjHaswAv1BKCkUgmIt0xvPIf16D3NwOWAcr8O1pNqc2EHjnE5BUCd_UmY5sqlYF3s1VczlPGEqNq959UOJXXJNKjryDiqyYKsKTxV8GV-UMQyJWLXYQ8GYRyFKsT7QpHIgkmrBs3wyWETEUtiq6CT_v_sFDt2OTXDZtBPoManFK3xDje6gi6LVL6RZ53Ctf37ZGXEH-ufNuVjOFuju8DmvZPAjwrEF1nD9pfYnkdofMC7VdHc8wHf4zcV__h4mR16seClWHAUCz4tFtyJBa_Egk_EYoXdnZ12j88D3ygjAIEKN0AjPUvbKeQ5SG20skKJBJQEodF-axkhbQRZbLXNIcEDMqVMZJRKE6WtyOO_bLY_6Ns1xpu5TA0Apb_TJMti4rtTOjO5laAjDetstfgyD8OCDeWh_GYbX85ssj-VoG2xuRx_P7uNttzI7DjA3gCb4Ujw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Seizure+activity+and+unresponsiveness+after+hydroxycut+ingestion&rft.jtitle=Pharmacotherapy&rft.au=Kockler%2C+D+R&rft.au=McCarthy%2C+M+W&rft.au=Lawson%2C+C+L&rft.date=2001-05-01&rft.issn=0277-0008&rft.volume=21&rft.issue=5&rft.spage=647&rft_id=info:doi/10.1592%2Fphco.21.6.647.34542&rft_id=info%3Apmid%2F11349754&rft_id=info%3Apmid%2F11349754&rft.externalDocID=11349754
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-0008&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-0008&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-0008&client=summon